Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Luckily for you, we built StockStory to help you separate the good from the bad. Keeping that in mind, here is one cash-producing company that leverages its financial strength to beat its competitors and two that may face some trouble.
Two Stocks to Sell:
Procter & Gamble (PG)
Trailing 12-Month Free Cash Flow Margin: 18.1%
Founded by candle maker William Procter and soap maker James Gamble, Procter & Gamble (NYSE: PG) is a consumer products behemoth whose product portfolio spans everything from facial tissues to laundry detergent to feminine care to men’s grooming.
Why Does PG Worry Us?
- Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 2.3% over the last three years was below our standards for the consumer staples sector
- Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
- Projected sales growth of 2.7% for the next 12 months suggests sluggish demand
Procter & Gamble’s stock price of $140.42 implies a valuation ratio of 20.8x forward P/E. To fully understand why you should be careful with PG, check out our full research report (it’s free).
PACCAR (PCAR)
Trailing 12-Month Free Cash Flow Margin: 13.1%
Founded more than a century ago, PACCAR (NASDAQ: PCAR) designs and manufactures commercial trucks of various weights and sizes for the commercial trucking industry.
Why Do We Think Twice About PCAR?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 11.4% annually over the last two years
- Earnings per share have dipped by 30.2% annually over the past two years, which is concerning because stock prices follow EPS over the long term
- Waning returns on capital imply its previous profit engines are losing steam
At $109.48 per share, PACCAR trades at 18.5x forward P/E. Dive into our free research report to see why there are better opportunities than PCAR.
One Stock to Buy:
Alignment Healthcare (ALHC)
Trailing 12-Month Free Cash Flow Margin: 5.3%
Founded in 2013 with a mission to transform healthcare for seniors, Alignment Healthcare (NASDAQ: ALHC) provides Medicare Advantage health plans for seniors with features like concierge services, transportation benefits, and technology-driven care coordination.
Why Are We Bullish on ALHC?
- Annual revenue growth of 45.4% over the last two years was superb and indicates its market share increased during this cycle
- Earnings per share grew by 28.5% annually over the last four years, massively outpacing its peers
- Free cash flow margin grew by 11 percentage points over the last five years, giving the company more chips to play with
Alignment Healthcare is trading at $13.25 per share, or 16.8x forward EV-to-EBITDA. Is now the time to initiate a position? Find out in our full research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
